Greencoat Renewables, Keppel agree second 10 year Power Purchase Agreement
Under the terms of the PPA, Singapore-listed Keppel DC REIT will purchase 100% of the electricity generated from Greencoat Renewables' Ballincollig wind farm in Co Kerry, which has an annual output of 31.5 GWh of renewable energy.
The PPA for the Ballincollig wind farm is the sixth PPA within the Greencoat Renewables portfolio and the company said the deal underscores its capability to re-contract assets as they transition out of tariff regimes.
The six PPAs amount to about 540 GWh of renewable energy a year and represent about 20% of Greencoat Renewables five year look forward merchant volumes.
Paul O'Donnell, Partner, Schroders Greencoat LLP, said that as one of Europe's leading listed owners and operators of renewable energy infrastructure assets, it sees a significant opportunity to provide renewable electricity to the growing Irish data centre market.
"Our second PPA with Keppel DC REIT further strengthens our position as a trusted provider of renewable energy, supporting our partners with their decarbonization efforts and advancing the energy transition," he said.
"Looking ahead, data centres powered by renewable energy will be a key industrial enabler for the next phase of economic development. Greencoat Renewables is strategically positioned to deliver cost-effective, clean power - supporting the ambitions of our partners and contributing to sustainable economic growth," he added.
Gary Watson, Country Manager, Keppel DC REIT (Ireland), said the company was delighted to meet its 2030 target of using 100% Irish renewable energy for its operations five years ahead of schedule.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
8 minutes ago
- Irish Examiner
MSD won't close Irish sites as part of $3bn cutbacks
Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. MSD yesterday announced a global cost-cutting exercise as it prepares for generic competition to its Irish-manufactured cancer drug Keytruda, the world's best-selling medicine, which is predominantly made in Ireland. The company will cut administrative, sales and research jobs, with increased focus on the US market. It has not said where the roles will be lost or if any Irish workers will be among those affected. However, a spokesperson told the Irish Examiner: "The restructuring announced today does not include site closures in Ireland." MSD employs more than 3,000 people at eight locations in Ireland. These include MSD Brinny in Co Cork specialising in development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines; three facilities in Dublin (MSD Biotech, MSD Blackrock, and MSD Red Oak North); MSD Carlow; MSD Dunboyne in Co Meath; MSD Ballydine in Co Tipperary, the company's first Irish site; and MSD Dundalk, the former WuXi Vaccines sites acquired in January. The cost cuts will include $1.7bn (€1.47bn) in annual savings from the elimination of certain administrative, sales and R&D positions, MSD said. The company expects the restructuring to be completed by the end of 2027, the year before Keytruda's key patents expire and the drug faces US government price cuts. The company said it plans to reinvest the savings into developing new drugs and launching new products. EU-branded medicines will face 15% import tariffs under the new transatlantic trade deal agreed between the European bloc and the US at the weekend. Like many other pharmaceutical firms based in Ireland, MSD had stockpiled doses of Keytruda manufactured in Ireland, to protect itself from tariffs imposed in 2025. MSD previously disclosed plans to invest more than $9bn (€7.78bn) in US manufacturing over the next four years, part of an effort to make more of its medicines in the US. The company reiterated that it expects to spend $200m (€172m) on tariffs in 2025, a number that reflects levies already in place and doesn't account for future tariffs on pharmaceuticals.
The Irish Sun
an hour ago
- The Irish Sun
US patients will pay cost of Donald Trump's 15 per cent tariffs on EU's pharma industry, Irish boss warns
AMERICAN patients will pay the cost of Donald Trump's 15 per cent tariffs on Europe's pharmaceutical industry, an Irish pharma company boss has warned. The Advertisement 2 CEO of Nutriband Gareth Sheridan fears the impact of the tariffs There Tanaiste Gareth Sheridan is CEO of Nutriband – a pharma company that specialises in patch technologies to enable safer use of pain medications and reduces the risk of addiction. The company is in a unique position in that they are based in the US and so will not face the 15 per cent tariffs. Advertisement Read more in News However, He told the Irish Sun: 'We won't be hugely impacted by the tariffs directly but we will be because we will be caught up in the industry impact. 'As a company that likes to describe ourselves as patient focused, we're very concerned at the effect that this will have on patients at the end of the day. 'Primarily that is where the fallout is going to be. To give you an example, 60 per cent of patients battling cancer in America today struggle with the cost of care as it is – and that's without a 15 per cent hike. Advertisement Most read in Irish News 'If you can imagine a 15 per cent hike in the cost of any sort of chemotherapies that is now being imported at a US level – that is very problematic. 'That's about two million people that are today barely making ends meet because of the cost of chemotherapy and you're going to have a 15 per cent price hike most likely unless the pharmaceutical companies absorb that cost.' US and EU agree landmark trade deal after months of talks, Donald Trump says The Irish pharma company boss believes that patients are being left behind in the discussion on tariffs as the majority of the discussion has been about the impact on jobs and the economy. He said: 'When it comes to negotiations and these discussions, ultimately people aren't statistics and patients need to be kept top of the narrative. Advertisement 'When we were talking bigger numbers and job losses and how its going to effect the economy and all those things – that's terrible. 'But ultimately when people are going to die - and they will die because they can't afford to live - I think that is a very dangerous precedent to set globally.' RESPONSE TEAM SET UP It comes as Business Minister Peter Burke established a Tariff Response Team to support Irish exporters who will be hit by the new 15 per cent tariffs. The trade team will give advice to businesses and manage new grants and funds that are being made available to assist Irish companies. Advertisement These include new market discover funds of up to €150,000 to help companies expand to new countries and €35,000 research grants to help firms mitigate the impact of the trade shake up. 2 The US clarified that pharma exports from the EU will be included in the tariffs Credit: Christopher Furlong/Pool via REUTERS
Irish Post
an hour ago
- Irish Post
Tesco continues Irish investment with €3.5m renovation of Cavan store
TESCO has unveiled a new look store in Co. Cavan which has undergone a €3.5m refurbishment. The 24,000 sq. ft. store in Virginia is the latest branch of the British supermarket chain's Irish operations to receive an overhaul. Located at the Virginia Shopping Centre, the branch is Tesco's third store in the county, with outlets already in Cavan Town and Bailieborough. It has been refitted and rebranded since Tesco acquired what was formerly McEvoy's supermarket earlier this year. 'The store has been modernised throughout with new shelving, floors, refrigeration, heating and lighting, as well as upgrades to back offices and colleague facilities,' a Tesco spokesperson confirmed. Tesco has unveiled a new-look store in Virginia, Co. Cavan 'The store also has a large new fresh food department, off-licence, bakery and Deposit Return Machine.' Store Manager Conor Tully will lead a team of 50 staff in Virginia, many of whom having moved over from the previous store. A host of Cavan-based brands can also be found on the shelves including customer favourites Barry John's sausages, Manor Hill Tarts, McCloskey's bread, Crust & Crumb pizzas, Moran's jam, and Champion Milk to name a few. 'The store has undergone a huge change with upgrades to every aspect of the shop enhancing the shopping experience for customers,' Tully said. 'We are delighted to have so many local producers stocked in store with plans to add more in the coming weeks and months.' Last week Tesco opened a new superstore in Fermoy, Co. Cork Speaking at the official reopening, Cathaoirleach of Cavan County Council, Councillor John Paul Feeley said: 'We are delighted to see Tesco open in Virginia, giving a welcome boost to the local economy. It is a fantastic new store, offering a truly modern shopping experience, which the people of the town and surrounding areas can enjoy for many years to come.' Tesco Ireland CEO Geoff Byrne says he's delighted with the newly renovated store. 'This newly revamped store is a great addition to our store network and brings the total number of stores we now have across Ireland to 185," he said. "We're proud to be part of the local community in Virginia and want to make a positive impact going forward.' The British supermarket chain is continuing to invest in its Irish operations this year. Earlier this month it spent €5m on a major transformation of its store in Ballina, Co. Mayo. Last week the firm officially opened a new €20m superstore in Co. Cork. Located in Fermoy the 39,000 sq. ft. purpose-built store also saw the creation of 100 new jobs. See More: Cavan, Cork, Fermoy, Ireland, Tesco, Virgina
